[1]刘 培,彭 俊,李书楠,等.益气养阴活血利水法联合康柏西普对非增殖期糖尿病视网膜病变患者视网膜电图的影响*[J].陕西中医,2020,(6):728-732.[doi:DOI:10.3969/j.issn.10007369.2020.06.008]
　LIU Pei,PENG Jun,LI Shunan,et al.Effect of Yiqi Yangyin Huoxue Lishui combined with conbercept on electroretinogram in non-proliferative diabetic retinopathy[J].,2020,(6):728-732.[doi:DOI:10.3969/j.issn.10007369.2020.06.008]
点击复制

益气养阴活血利水法联合康柏西普对非增殖期糖尿病视网膜病变患者视网膜电图的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年6期
页码:
728-732
栏目:
临床研究
出版日期:
2020-06-01

文章信息/Info

Title:
Effect of Yiqi Yangyin Huoxue Lishui combined with conbercept on electroretinogram in non-proliferative diabetic retinopathy
作者:
刘 培1; 2; 彭 俊2; 李书楠1; 曾志成3; 覃艮艳4; 姚小磊2; 陈向东2; 蒋鹏飞1; 彭清华1△
1.湖南中医药大学(长沙410208); 2.湖南中医药大学第一附属医院(长沙410007); 3.湖南省桂阳县第一人民医院(郴州424400); 4.湖南省常德市第一中医院(常德415000)
Author(s):
LIU Pei; PENG Jun; LI Shunan; et al.
Hunan University of Chinese Medicine(Changsha 410208)
关键词:
益气养阴;  活血利水;  非增殖期糖尿病视网膜病变;  康柏西普;  视网膜电图;  血管内皮生长因子
Keywords:
Yiqi Yangyin;  Huoxue Lishui;  Nonproliferative diabetic retinopathy;  Conbercept;  Electroretinogram;  Vascular endothelial growth factor
分类号:
R256
DOI:
DOI:10.3969/j.issn.10007369.2020.06.008
文献标志码:
A
摘要:
目的:观察益气养阴活血利水法联合康柏西普对非增殖期糖尿病视网膜病变(NPDR)患者视网膜电图(ERG)的影响。方法:60例(82眼)NPDR患者,采用随机数字表法分为两组,对照组30例(40眼)玻璃体腔注射康柏西普,每月1次,治疗组30例(42眼)在对照组的基础上加用益气养阴活血利水中药口服治疗。治疗3个月后,观察两组患者BCVA、ERG,OCT检测两组患者CMT情况。结果:两组患者治疗前后不同时间BCVA、暗适应及明适应ab波振幅、CMT差异有统计学意义(P<0.05),治疗后不同时间两组患者BCVA、明暗适应ab波振幅、CMT相比,差异均有统计学意义(P<0.05)。结论:益气养阴活血利水法联合康柏西普较单纯康柏西普治疗能更好的减轻NPDR患者视网膜水肿,提高视力、暗适应及明适应a、b波振幅,降低CMT。
Abstract:
Objective:To observe the effect of Yiqi Yangyin Huoxue Lishui combined with conbercept on ERG in NPDR.Methods:60 patients(82 eyes)with NPDR were randomly divided into two groups,30 patients in the control group(40 eyes)with intravitreal injection of conbercept,once a month,and 30 patients in the treatment group(42 eyes)in the control group.On the basis of the addition of Yiqi Yangyin Huoxue Lishui oral treatment.After 3 months of treatment,BCVA and ERG,OCT were used to detect the CMT of the two groups.Results:There were significant differences in BCVA,a-b wave amplitudes of dark adaptation and bright adaptation amplitude and CMT between the two groups before and after treatment(P<0.05).There were significant differences in BCVA,a-b wave amplitudes of dark adaptation and a-b wave amplitude and CMT between the two groups after treatment(P<0.05).Conclusion:Compared with conbercept,it can better reduce retinal edema in NPDR patients,improve visual acuity,dark adaptation and bright adaptation,reduce CMT.

参考文献/References:

[1]Kowluru RA.Mitochondrial stability in diabetic retinopathy:lessons learned from epigenetics[J].Diabetes,2019,68(2):241-247.
[2] Zhou P,Xie W,Meng X,et al.Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent activation of mitophagy[J].Cells,2019,8(3):213.
[3] Mishra M,Duraisamy AJ,Bhattacharjee S,et al.Adaptor protein p66Shc:a link between cytosolic and mitochondrial dysfunction in the development of diabetic retinopathy[J].Antioxidants & Redox Signaling,2019,30(13):1621-1634.
[4] Tso MOM,Suarez MJ,Eberhart CG.Pathologic study of early manifestations of polypoidal choroidal vasculopathy and pathogenesis of choroidal neo-vascularization[J].American Journal of Ophthalmology Case Reports,2018,11:176-180.
[5] Cheng C,Lai T,Ruamviboonsuk P,et al.Polypoidal choroidal vasculopathy:definition,pathogenesis,diagnosis,and management[J].Ophthalmology,2018,125(5):708-724.
[6] Takahashi Y,Koizumi H,Hasegawa T,et al.Comparison of subfoveal choroidal structures in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy[J].Japanese Journal of Ophthalmology,2018,62(5):576-583.
[7] 赵堪兴,杨培增.眼科学[M].北京:人民卫生出版社,2013:217-219.
[8] 李传课.中医眼科学[M].北京:人民卫生出版社,2011:616-618.
[9] Yan J.Effects of photodynamic therapy with ranibizumab on visual acuity and postoperative complications in patients with PCV complicated with vitreous hemorrhage[J].International Eye Science,2018,18(12):2209-2212.
[10] 曾志成,彭 俊,沈志华,等.益气养阴活血利水法对高度近视孔源性视网膜脱离复位术后残留视网膜下液的影响[J].中华中医药杂志,2019,34(5):2017-2021.
[11] 曾志成,彭 俊,蒋鹏飞,等.益气养阴活血利水复方联合玻璃体腔注射康柏西普治疗糖尿病性黄斑水肿疗效观察[J].中国中西医结合杂志,2019,39(3):270-274.
[12] 王吉利,赵艳龙.黄芪多糖含量的相关种植因素研究[J].陕西中医,2019,40(12):1803-1806.
[13] 梁 文,杨敏飞,黄 鑫.党灵杞糖浆的提取工艺及质量标准探讨[J].陕西中医,2019,40(5):674-677.
[14] 杜战国.生蒲黄汤治疗非增殖型糖尿病视网膜病变临床研究[J].陕西中医,2018,39(7):897-899.
[15] 朱 莺.生蒲黄汤治疗眼底出血疗效观察[J].陕西中医,2011,32(1):41-42.
[16] 蒋鹏飞,董子奕,彭 俊,等.蛴螬提取物对视网膜中央静脉阻塞模型兔小胶质细胞CD68表达的影响及机制研究[J].中国现代医学杂志,2019,29(12):7-11.
[17] 蒋鹏飞,马俊旭,彭 俊,等.蛴螬提取物对实验性兔视网膜静脉阻塞不同时间窗MMP-9表达的影响[J].中国医药导报,2019,16(15):8-11,181.
[18] 蒋鹏飞,彭 俊,吴大力,等.蛴螬提取物对兔光损伤视网膜变性Caspase 8、Bax、Bid及Caspase 3表达的影响[J].中华眼科医学杂志:电子版,2019,9(2):83-89.
[19] 张庆镐,朴奎善,李基俊,等.蛴螬矿物元素和维生素含量分析[J].微量元素与健康研究,2002,19(1):30-31.
[20] 何 花,张 虹,王志涛,等.精氨酸一甘氨酸一天门冬氨酸一丝氨酸肽对实验性脉络膜新生血管的抑制作用[J].中华眼科杂志,2006,42(9):825-831.
[21] 刘 彦,陈建华,赵慧英,等.康柏西普玻璃体腔注射联合激光光凝对糖尿病黄斑水肿患者脉络膜厚度的影响[J].陕西医学杂志,2019,48(8):1063-1065,1073.

相似文献/References:

[1]高德慧,刘寨东△.基于肝藏象理论的肿瘤微环境视角下肝肿瘤中医证治*[J].陕西中医,2020,(9):1282.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.030]
[2]陈雨欣,王 文,程大鹏,等.名中医温建民治疗拇外翻术后经验[J].陕西中医,2024,(9):1249.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.023]
　CHEN Yuxin,WANG Wen,CHENG Dapeng,et al.Experience of national famous TCM practitioner WEN Jianmin in treating after hallux valgus surgery[J].,2024,(6):1249.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.023]

备注/Memo

备注/Memo:
*国家自然科学基金资助项目(81804150,81603664);中医药防治眼耳鼻咽喉疾病与视功能保护湖南省工程技术研究中心建设项目(2018TP2008)
更新日期/Last Update: 2020-06-09